Gocovri
(AMANTADINE)Adamas Pharma, LLC
Usage: GOCOVRI® is indicated for treating dyskinesia in Parkinson’s disease patients on levodopa therapy, with or without additional dopaminergic medications, and as an adjunctive treatment to levodopa/carbidopa for patients experiencing “off” episodes.